Does CANAKINUMAB Cause Off label use? 557 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 557 reports of Off label use have been filed in association with CANAKINUMAB (Ilaris). This represents 5.3% of all adverse event reports for CANAKINUMAB.
557
Reports of Off label use with CANAKINUMAB
5.3%
of all CANAKINUMAB reports
97
Deaths
299
Hospitalizations
How Dangerous Is Off label use From CANAKINUMAB?
Of the 557 reports, 97 (17.4%) resulted in death, 299 (53.7%) required hospitalization, and 272 (48.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 557 reports have been filed with the FAERS database.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Arthralgia (555)
Rash (505)
Incorrect dose administered (497)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CANAKINUMAB Alternatives Have Lower Off label use Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN